The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The inhibition of neuronal apoptosis in acute traumatic and ischemic injuries as well as in long term neurodegenerative disorders like spinal muscular atrophy and possibly Alzheimer's disease is a fundamental requirement for a therapeutic strategy. In this study we used an established in vivo model system of induction of neuronal apoptosis in the CNS to evaluate the properties of the X-linked inhibitor of apoptosis protein (XIAP) to inhibit secondary cell death after axonal lesions. We used adenoviral vectors to transduce retinal ganglion cells after axotomy of the optic nerve of adult rats. Vector application was performed at the optic nerve stump so that only the lesioned retinal neurons could be transduced. We found XIAP to be as effective as the viral broad spectrum caspase inhibitor protein p35. These findings suggest that axotomized RGCs degenerate through class II caspase activity and furthermore offer the possibility of using mammalian XIAP protein to inhibit neuronal apoptosis as a basis for a regenerative therapy in the CNS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intriguingly, SOD1 and SOD2 are not broadly essential in other human cell types, including pluripotent stem cells11–13 and cancer cells14, suggesting a selective vulnerability to oxidative stress of neurons.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [11]
Citations
Cites
Caspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719 · cited 1×
“The apoptotic program is executed by a family of specialized proteases termed caspases.(11,12) The activation of inactive zymogens and the activity of the caspases can be inhibited by proteins expressed either by viruses or endogenously in mammalian cells.”
BackgroundProgrammed Cell Death in Animal Development
Jacobson, M. D., Weil, M., & Raff, M. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81873-5 · Cited by 2,698
Nicholson, D. W., & Thornberry, N. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01085-2 · Cited by 2,409 · cited 1×
“The apoptotic program is executed by a family of specialized proteases termed caspases.(11,12) The activation of inactive zymogens and the activity of the caspases can be inhibited by proteins expressed either by viruses or endogenously in mammalian cells.”
BackgroundX-linked IAP is a direct inhibitor of cell-death proteases
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., & Reed, J. C. (1997) · Nature · doi:10.1038/40901 · Cited by 1,955 · cited 2×
“While CrmA and the Flips target the DISC-complex and inhibit caspase 8 activation,(15,21) the IAPs directly inhibit the effector caspases 3 and 7, the BIR3-Ring domains of XIAP have also inhibitory properties for caspase 9.(17,19,22) p35 is a broad spectrum caspase inhibitor with similar Ki for all caspases tested.”
BackgroundMethodTamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,397
Deveraux, Q. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2215 · Cited by 1,388 · cited 3×
“While CrmA and the Flips target the DISC-complex and inhibit caspase 8 activation,(15,21) the IAPs directly inhibit the effector caspases 3 and 7, the BIR3-Ring domains of XIAP have also inhibitory properties for caspase 9.(17,19,22) p35 is a broad spectrum caspase inhibitor with similar Ki for all caspases tested.”
BackgroundMethodResultViral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Burns, K., Bodmer, J.-L., Schröter, M., et al. (1997) · Nature · doi:10.1038/386517a0 · Cited by 1,315 · cited 1×
“Viral anti-apoptotic proteins include p35 and IAP from baculovirus,(13,14) CrmA from cowpoxvirus(15) and the v-Flip proteins from herpes viruses.(16) Several mammalian homologs of these viral proteins have been identified.”
BackgroundThe c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
Roy, N. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6914 · Cited by 1,301
Roy, N., Mahadevan, M. S., McLean, M., Shutter, G., Yaraghi, Z., Farahani, R., Baird, S., Besner-Johnston, A., Lefebvre, C., Kang, X., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90461-1 · Cited by 981
Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia
Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A., Tomaselli, K. J., Yuan, J., & Moskowitz, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03659.1998 · Cited by 893 · cited 1×
“Apoptotic neuronal cell death has been claimed to contribute to neurodegenerative disorders such as spinal muscular atrophy,(3) and Alzheimer's disease(4) ± 6 and is also responsible for cell loss after ischemia and traumatic injury.(7) ± 10 It is of great clinical importance to reduce the neuronal cell loss as much a…”
Background
Cited by
The inhibitors of apoptosis: there is more to life than Bcl2
Liston, P., Fong, W. G., & Korneluk, R. G. (2003) · Oncogene · doi:10.1038/sj.onc.1207101 · Cited by 440
Self-citationMitochondrial membrane permeabilization in neuronal injury
Galluzzi, L., Blomgren, K., & Kroemer, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2665 · Cited by 418
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414
“Among these genes, we identified known regulators of apoptosis, such as TP53, IKBIP, and factors specifically of neuronal survival, such as XIAP (Kügler et al., 2000; Tsang et al., 2009; Unsain et al., 2013; Xu et al., 1999), GDPGP1 (Schulz et al.”
BackgroundXIAP: Apoptotic brake and promising therapeutic target
Holcik, M., Gibson, H., & Korneluk, R. G. (2001) · Apoptosis · doi:10.1023/a:1011379307472 · Cited by 385
Susceptibility to Neurodegeneration in a Glaucoma Is Modified by Bax Gene Dosage
Libby, R. T., Li, Y., Savinova, O. V., Barter, J., Smith, R. S., Nickells, R. W., & John, S. W. M. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010004 · Cited by 358
Cheng, G., Kong, R., Zhang, L., & Zhang, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02025.x · Cited by 343
“Second, members like XIAP, c-IAP1, c-IAP2 and survivin bind and suppress enzyme catalytic activity (Kugler et al., 2000; Perrelet et al., 2000).”
BackgroundLegewie, S., Blüthgen, N., & Herzel, H. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020120 · Cited by 241
Apoptotic cell death regulation in neurons
Hollville, E., Romero, S. E., & Deshmukh, M. (2019) · The FEBS Journal · doi:10.1111/febs.14970 · Cited by 214
Neural stem cell differentiation is dependent upon endogenous caspase‐3 activity
Fernando, P., Brunette, S., & Megeney, L. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2981fje · Cited by 210
Shevtsova, Z., Malik, J. M. I., Michel, U., Bähr, M., & Kügler, S. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2004.028159 · Cited by 207
“Initial studies have been accomplished by the use of adenoviral vectors, which, however, can transduce RGCs only in a retrograde application approach (Kügler et al. 1999, 2000).”
BackgroundSelf-citationMolecular determinants of retinal ganglion cell development, survival, and regeneration
Isenmann, S. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(03)00027-2 · Cited by 192
Self-citationKügler, S., Meyn, L., Holzmüller, H., Gerhardt, E., Isenmann, S., Schulz, J. B., & Bähr, M. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0929 · Cited by 185
Self-citationBaculoviral IAP Repeat-Containing-4 Protects Optic Nerve Axons in a Rat Glaucoma Model
McKinnon, S. J., Lehman, D. M., Tahzib, N. G., Ransom, N. L., Reitsamer, H. A., Liston, P., LaCasse, E., Li, Q., Korneluk, R. G., & Hauswirth, W. W. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0608 · Cited by 163
Self-citationSánchez-Migallón, M. C., Valiente‐Soriano, F. J., Nadal-Nicolás, F. M., Vidal‐Sanz, M., & Agudo‐Barriuso, M. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17841 · Cited by 153
Targeting post-mitochondrial effectors of apoptosis for neuroprotection
Galluzzi, L., Morselli, E., Kepp, O., & Kroemer, G. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.09.006 · Cited by 128
van Adel, B. A., Kostic, C., Déglon, N., Ball, A. K., & Arsenijévic, Y. (2003) · Human Gene Therapy · doi:10.1089/104303403321070801 · Cited by 121
The crucial role of caspase‐9 in the disease progression of a transgenic ALS mouse model
Inoue, H., Tsukita, K., Iwasato, T., Suzuki, Y., Tomioka, M., Tateno, M., Nagao, M., Kawata, A., Saido, T. C., Miura, M., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg634 · Cited by 113
Wang, X., Zhu, C., Wang, X., Hagberg, H., Korhonen, L., Sandberg, M., Lindholm, D., & Blomgren, K. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.014 · Cited by 107
“Adenovirally mediated ectopic expression of XIAP protected retinal ganglion cells against axotomy (Kugler et al., 2000), and dopaminergic neurons subjected to MPTP (Eberhardt et al.”
BackgroundNeuronal pathology in Parkinson?s disease
Schulz, J. B. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1081-0 · Cited by 101
“AdV-HIAP2, AdV-NAIP, AdV-p35, AdV-crmA) against apoptotic stimuli and have found XIAP expression to be the most effective (Simons et al. 1999; Kügler et al. 2000; Gerhardt et al. 2001).”
BackgroundGrowth and guidance cues for regenerating axons: Where have they gone?
Koeberle, P. D., & Bähr, M. (2004) · Journal of Neurobiology · doi:10.1002/neu.10345 · Cited by 100
Self-citationNeuronal pathology in Parkinson?s disease
Schulz, J. B., & Falkenburger, B. H. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0954-y · Cited by 127
RetractedInda, M. C., Joshi, S., Wang, T., Bolaender, A., Gandu, S. R., Koren, J., Yue, A., Taldone, T., Yan, P., Sun, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14082-5 · Cited by 92
Gene therapy for retinal ganglion cell neuroprotection in glaucoma
Wilson, A. M., & Polo, A. D. (2011) · Gene Therapy · doi:10.1038/gt.2011.142 · Cited by 95
Schmeer, C. W., Straten, G., Kügler, S., Gravel, C., Bähr, M., & Isenmann, S. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01893.x · Cited by 81
“Whilst immunocytochemistry for the myc protein on retinal sections was not speci®c for transduced cells (KuÈgler et al., 2000), speci®c detection of virally mediated GDNF mRNA expression can be achieved by RTPCR with primers comprising the GDNF±myc fusion region present in the transgene but not in…”
BackgroundSelf-citationAdvances in gene therapy for diseases of the eye
Petit, L., Khanna, H., & Punzo, C. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.040 · Cited by 82
XIAP Protection of Photoreceptors in Animal Models of Retinitis Pigmentosa
Leonard, K. C., Petrin, D., Coupland, S. G., Baker, A. N., Leonard, B. C., LaCasse, E. C., Hauswirth, W. W., Korneluk, R. G., & Tsilfidis, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000314 · Cited by 82
Francés, D. E., Ronco, M. T., Monti, J. A., Ingaramo, P. I., Pisani, G. B., Parody, J. P., Pellegrino, J. M., Sanz, P. M., Carrillo, M. C., & Carnovale, C. E. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0462 · Cited by 80
“Extensive data from both in vitro and in vivo systems have demonstrated that increasing XIAP can suppress apoptosis triggered by diverse stimuli (Case et al. 1999, Kugler et al. 2000).”
BackgroundApoptotic Cell Death Following Traumatic Injury to the Central Nervous System
Springer, J. E. (2002) · BMB Reports · doi:10.5483/bmbrep.2002.35.1.094 · Cited by 80
“The first identified IAP family member was p35, a baculoviral protein that suppresses apoptosis in a number of cell types (including cells of the CNS) and under a variety of conditions (Rabizadeh et al., 1993; Simons et al., 1999; Xu et al., 1999; Eberhardt et al., 2000; Hisahara et al., 2000; Kugler et al., 2000; Kor…”
BackgroundRecent developments in ocular gene therapy
Borrás, T. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00030-7 · Cited by 74
Hypothesis for a Common Basis for Neuroprotection in Glaucoma and Alzheimer's Disease
Tatton, W. G., Chen, D., Chalmers-Redman, R. M. E., Wheeler, L. A., Nixon, R. A., & Tatton, N. A. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00005-5 · Cited by 81
Straten, G., Schmeer, C. W., Kretz, A., Gerhardt, E., Kügler, S., Schulz, J. B., Gravel, C., Bähr, M., & Isenmann, S. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0543 · Cited by 71
“Likewise, the viral caspase inhibitor p35 and the evolutionarily conserved mammalian caspase inhibitor XIAP (X-chromosome-linked inhibitor of apoptosis; Deveraux et al., 1997, 1998) rescue RGCs following adenoviral gene transfer (Kügler et al., 1999, 2000).”
BackgroundSelf-citationThe X-Linked Inhibitor of Apoptosis Protein Enhances Survival of Murine Islet Allografts
Plesner, A., Liston, P., Tan, R., Korneluk, R. G., & Verchere, C. B. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2533 · Cited by 67
“Notably, overexpression of XIAP is capable of preventing apoptosis induced by a variety of triggers in vitro and has been shown to inhibit cell death in several models of neurodegeneration in vivo, including neuronal ischemia (11), axotomy (12,13), glaucoma (14), and MPTP (1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine)…”
BackgroundSelf-citationGene‐based treatment of motor neuron diseases
Federici, T., & Boulis, N. M. (2005) · Muscle & Nerve · doi:10.1002/mus.20439 · Cited by 70
Clayton, R., Clark, J. B., & Sharpe, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02918.x · Cited by 64
“Inhibitors of apoptosis proteins (IAPs), in particular, are emerging as important players and, as such, their therapeutic potential is being considered for conditions in which dysregulation of apoptosis is the primary mechanism (Xu et al. 1999; Kugler et al. 2000).”
BackgroundPetrin, D., Baker, A. N., Coupland, S. G., Liston, P., Narang, M. A., Damji, K. F., Leonard, B. C., Chiodo, V. A., Timmers, A. M., Hauswirth, W. W., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0729 · Cited by 60
“In the eye, intravitreal gene delivery of XIAP using an adenoassociated virus (AAV) shows protection of optic nerve axons in a hypertensive rat model of glaucoma(27) and Ad-XIAP has been shown to protect axotomized retinal ganglion cells from cell death.(28) In the present study, we examine the neuroprotective effects…”
BackgroundSelf-citationAttenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice
Crocker, S. J., Liston, P., Anisman, H., Lee, C. J., Smith, P. D., Earl, N., Thompson, C. S., Park, D. S., Korneluk, R. G., & Robertson, G. S. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00020-7 · Cited by 55
Self-citationDendritic and Synaptic Protection: Is It Enough to Save the Retinal Ganglion Cell Body and Axon?
Morquette, J. B., & Di Polo, A. (2008) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318177edf0 · Cited by 51
Gene delivery to the retina: focus on non-viral approaches
Naik, R. J., Mukhopadhyay, A., & Ganguli, M. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.012 · Cited by 59
Effects on XIAP Retinal Detachment–Induced Photoreceptor Apoptosis
Zadro-Lamoureux, L. A., Zacks, D. N., Baker, A. N., Zheng, Q.-D., Hauswirth, W. W., & Tsilfidis, C. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2855 · Cited by 40
Neuroprotective Properties of Different Anesthetics on Axotomized Rat Retinal Ganglion Cells In Vivo
Özden, S., & Isenmann, S. (2004) · Journal of Neurotrauma · doi:10.1089/089771504772695968 · Cited by 38
“RGC apoptosis is regulated by Bcl-2 family proteins (Isenmann et al., 1999; Isenmann et al., 1997), and caspases-3 and -9 play a role both in the regulation and execution of secondary RGC death (Kermer et al., 2000; Kermer et al., 1998; Kügler et al., 2000).”
InfluentialSelf-citationEllenberg, D., Shi, J. L., Jain, S. K., Chang, J., Ripps, H., Brady, S., Melhem, E. R., Lakkis, F. G., Adamis, A. P., Chen, D.-F., et al. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.155267 · Cited by 36
Pan, Q., Liu, B., Liu, J., Cai, R., Liu, X., & Qian, C. (2007) · Acta Oncologica · doi:10.1080/02841860701403053 · Cited by 34
Siebert, J. R., Middleton, F. A., & Stelzner, D. J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-148 · Cited by 38
“The expression profiles for Stat1, Table 2 PCR Primers Gene Symbol Accession # Left Primer Right Primer Product Size Abcb5 XM_234725 CTGATAGAGCATGGCTTTGAATG GGTTGTTTTATGGCAGAGCAGA 77 Akt3 NM_031575 TGGAGAGGAAGAGATGGATGC TCCACTTGCCTTCTCTCGAAC 130 Arg1 NM_017134 TGGAACAATCAGTGTGGTGCT ATCCACCCAAATGACGCATAG 103 Atf3 NM_01…”
BackgroundUpadhyay, A., Amanullah, A., Chhangani, D., Mishra, R., & Mishra, A. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.009 · Cited by 35
“…et al. (2008) Trinh et al. (2001) Kurki et al. (2004) Olson et al. (1993) Colledge et al. (2003) XIAP Fado et al. (2013) Huang et al. (2013b) Kugler et al. (2000) Brady et al. (2010) Tran et al. (1999) Kairisalo et al. (2009) Smurf1 Guo et al. (2011) Bryan et al. (2005) Orvedahl et…”
1 Caspase Inhibitors as Anti-inflammatory and Antiapoptotic Agents
Graczyk, P. P. (2002) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70068-7 · Cited by 32
Cell-replacement therapy and neural repair in the retina
Schmeer, C. W., Wohl, S. G., & Isenmann, S. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1335-6 · Cited by 30
Self-citationCell Death in the Nervous System
KRIEGLSTEIN, K. G. (2007) · Springer eBooks · doi:10.1007/0-387-30128-3_1 · Cited by 32
A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis
Zhao, Z., Ho, L., Suh, J., Qin, W., Pyo, H., Pompl, P., Ksiezak-Reding, H., & Pasinetti, G. M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00175-1 · Cited by 31
Siegelin, M. D., Touzani, O., Toutain, J., Liston, P., & Rami, A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.006 · Cited by 27
Self-citationWang, X. H., Hu, J., Du, J., & Klein, J. D. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302927 · Cited by 28
Yao, J., Jia, L., Khan, N., Zheng, Q.-D., Moncrief, A., Hauswirth, W. W., Thompson, D. A., & Zacks, D. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037197 · Cited by 21
“Previous studies have shown that adeno-associated viral (AAV) constructs encoding XIAP exert protective effects in various models of retinal injury and disease including retinal ischemia [10], ganglion cell death induced by axotomy [11,12] or increased intraocular pressure [13], chemotoxic insult [14,15], retinal deta…”
BackgroundThe Healthy and Diseased Retina Seen through Neuron–Glia Interactions
Tempone, M. H., Borges-Martins, V. P. P., César, F. G. G., Alexandrino-Mattos, D. P., de Figueiredo, C. S., Raony, Í., dos Santos, A. A., Duarte-Silva, A. T., Dias, M. S., Freitas, H. R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021120 · Cited by 24
“…or delay the death of these cells, different neuroprotective mechanisms have been identified, such as the secretion of neurotrophic factors, the activation of antioxidant enzymes, the increased expression of anti-apoptotic proteins, the induction of autophagy, and proteostasis regulation [448–451].”
BackgroundHypoxia Alters The Expression of Inhibitor of Apoptosis Proteins after Brain Trauma in The Mouse
Mikrogianakis, A., Shaye, R. E., Griffin, P., Kawesa, S., Lockwood, J., Gendron, N. H., Gaboury, I., Merali, Z., MacKenzie, A., & Hutchison, J. S. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.003615 · Cited by 20
“Vector application of XIAP decreases cell death following axotomy (Kugler et al., 2000).”
Sansa, A., de la Fuente, S., Comella, J. X., Garcerá, A., & Soler, R. M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105366 · Cited by 19
“, Alzheimer’s disease, Huntington disease, amyotrophic lateral sclerosis, and axotomy) (Christie et al., 2007; Goffredo et al., 2005; Guégan et al., 2001; Kügler et al., 2000) and FAIM-L reduction is associated with the progression of Alzheimer’s disease (Carriba et al.”
BackgroundShan, H., Ji, D., Barnard, A. R., Lipinski, D. M., You, Q. S., Lee, E., Kamalden, T. A., Sun, X., & MacLaren, R. E. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6850 · Cited by 16
Isenmann, S., Schmeer, C. W., & Kretz, A. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.01.005 · Cited by 15
Self-citationPrunell, G., & Troy, C. M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20252 · Cited by 13
“Adenoviral expression of XIAP in the retinal ganglion cells provided as much protection as adenoviral ciliary neurotrophic actor (CNTF) or adenoviral p35 (Kugler et al., 2000).”
BackgroundXIAP GENE-BASED NEUROPROTECTIONFOR THE PERIPHERAL NERVOUS SYSTEM
Garrity‐Moses, M. E., Teng, Q., Krudy, C. A., Yang, J., Federici, T., & Boulis, N. M. (2006) · Neurosurgery · doi:10.1227/01.neu.0000219237.69329.b7 · Cited by 12
Cell death in glioblastoma and the central nervous system
Malone, K., LaCasse, E. C., & Beug, S. T. (2024) · Cellular Oncology · doi:10.1007/s13402-024-01007-8 · Cited by 13
“In sciatic nerve lesion models, the IAPs (especially XIAP and cIAP1/2) were found to be essential for cell survival, even without neurotrophic factor input [490].”
Weaver, J., McGregor, C. G. A., Tazelaar, H. D., & Badley, A. D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.05.017 · Cited by 10
Kisiswa, L., Albon, J., Morgan, J. E., & Wride, M. A. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.08.024 · Cited by 12
“Gene therapy delivery of XIAP/BIRC4 to the retinae of chronical ocular hypertensive (COH) model of rat glaucoma significantly promoted optic nerve axon survival (Kugler et al., 1999; Kugler et al., 2000; McKinnon et al., 2002).”
BackgroundLingor, P., Sch�ll, U., Bähr, M., & K�gler, S. (2004) · Experimental Brain Research · doi:10.1007/s00221-004-2077-9 · Cited by 9
Self-citationHe, M., Cheung, Z. H., Yu, E., Tay, D., & So, K. (2004) · Neurochemical Research · doi:10.1007/s11064-004-6889-6 · Cited by 9
“Many other factors such as caspase-9 exist in the pathway downstream of cytochrome c and upstream of caspase-3 which may affect the activation of caspase-3 directly or indirectly (48,49,58,59).”
BackgroundOverexpression of XIAP Inhibits Apoptotic Cell Death in an Oligodendroglial Cell Line
Jin, Y., McEwen, M. L., Ghandour, M. S., & Springer, J. E. (2004) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-6924-9 · Cited by 8
“, 1996) and has been shown to promote neuronal cell survival using in vitro and in vivo models of caspase-mediated apoptosis (Eberhardt et al., 2000; Holcik et al., 2001; Korhonen et al., 2001; Kugler et al., 2000; Simons et al., 1999; Xu et al., 1999).”
BackgroundApoptosis in Health and Disease: Apoptosis in health, disease, and therapy: overview and methodology
LaCasse, E., Holčík, M., Korneluk, R., & MacKenzie, A. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511663543.002 · Cited by 10
Tetrahydroisoquinolines – an updated patent review for cancer treatment (2016 – present)
Tanwar, A. K., Sengar, N., Mase, N., & Singh, I. P. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2391288 · Cited by 6
“Cell death is controlled through the apoptosis pathway and involves diverse biochemical events like cell shrinkage, micropore formation, membrane blebbing, nuclear condensation, DNA fragmentation and damage, enzyme dysfunctions etc [53,54].”
Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis
Holčík, M. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.3.241 · Cited by 9
“In a similar study, an adenoviral vector overexpressing XIAP was used to transduce retinal ganglion cells (RGC) following axotomy of the optic nerve [97] or intraocular pressure-induced glaucoma [98].”
BackgroundRoth, K. A. (2005) · Springer eBooks · doi:10.1007/0-387-28117-7_11 · Cited by 6
Hesse, A., Hagemeier, K., Lürbke, A., Held, J., Friedman, H. C., Peterson, A., Brück, W., & Kuhlmann, T. (2011) · Glia · doi:10.1002/glia.21261 · Cited by 5
Caspases; Modulators of Apoptosis and Cytokine Maturation — Targets for Novel Therapies
Knight, M. J., & Hawkins, C. J. (2006) · Springer eBooks · doi:10.1007/0-387-23695-3_4 · Cited by 4
“XIAP could also suppress apoptosis following optic nerve axotomy in a rat model (Kugler et al., 2000).”
BackgroundBähr, M., & Lingor, P. (2007) · Springer eBooks · doi:10.1007/0-387-30128-3_9 · Cited by 4
Self-citationProteomic analysis discovers potential biomarkers of early traumatic axonal injury in the brainstem
Chen, Q., Li, L., Xu, L., Yang, B., Huang, Y., Qiao, D., & Yue, X. (2023) · International Journal of Legal Medicine · doi:10.1007/s00414-023-03039-5 · Cited by 3
Survivin, other IAPs, Smac/Diablo, and Omi/Htra2 — Modulation of the Advancing Apoptotic Process
Li, F. (2006) · Springer eBooks · doi:10.1007/0-387-23695-3_6 · Cited by 3
Inhibitors of Apoptosis Proteins
Liston, P., Fong, W. G., & Korneluk, R. G. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-361-3_3 · Cited by 5
Self-citationWu, W., Wang, H., Zhang, L., Li, D., Chen, Y., Lin, B., Jiang, H., Meng, T., Zhu, Z., He, L., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1811373 · Cited by 1
“Notably, XIAP expression is significantly downregulated in A β - exposed neuronal cells and in AD brains, correlating with increased neuronal vulnerability (Kugler et al., 2000; Garranzo-Asensio et al., 2018; Barber et al., 2023).”
Anti-apoptotic proteins in nerve cell survival and neurodegeneration.
Korhonen, L. (2002) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 2
Neuroprotective Signaling Pathways in Glaucoma
Lebrun-Julien, F., & Polo, A. D. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-373-8_35 · Cited by 1
Apoptosis in neurodegenerative diseases
Schulz, J. B. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.008 · Cited by 1
Regulation of effector caspases by inhibitor of apoptosis (IAP) proteins
Choi, Y. E. (2008) · Texas ScholarWorks (Texas Digital Library)
Humphries, P., Humphries, M. M., Tam, L. C. S., Farrar, G. J., Kenna, P. F., Campbell, M., & Kiang, A. (2012) · SpringerBriefs in genetics · doi:10.1007/978-1-4614-4499-2_2
CASPASES; MODULATORS OF APOPTOSIS AND CYTOKINE MATURATION - TARGETS FOR NOVEL THERAPIES Chapter IV
Knight, M. J., & Hawkins, C. J. (2005)
Le mimétique de SMAC GDC-0152 : un nouvel immunomodulateur dans les glioblastomes
Snacel-Fazy, E. (2023) · theses.fr (ABES) · doi:10.70675/7e5e377fzaaa9z4f1dzbde6z9586007f6c3d
Shin, H. J., Park, H.-Y. L., & Park, C. K. (2026) · British Journal of Ophthalmology · doi:10.1136/bjo-2026-330371
Metadata
- Authors
- Kügler, S., Straten, G., Kreppel, F., Isenmann, S., Liston, P., & Bähr, M.
- Affiliations
- University of Tübingen (DE)
- Children's Hospital of Eastern Ontario (CA)
- Corresponding author
- Kügler, S
- Venue
- Cell Death & Differentiation
- Published
- 2000-08-30
- Volume
- 7
- Issue
- 9
- Pages
- 815-824
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2330153913
- Cited by
- 84
- References
- 42
- Citations by year
- 2026: 2 · 2024: 3 · 2023: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2016: 2 · 2015: 1 · 2012: 4
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- XIAP, inhibitor of apoptosis proteins, neuronal apoptosis, axotomy, retinal ganglion cells, optic nerve, axonal injury, p35, adenoviral gene transfer, neuroprotection, neurodegeneration, central nervous system regeneration
- MeSH terms
- Animals, Cell Survival, Genetic Vectors, Immunohistochemistry, Neurons, Optic Nerve, Proteins, Retina, Retinal Ganglion Cells, RNA, Apoptosis, Genes, Reporter, Transgenes, Axotomy, Reverse Transcriptase Polymerase Chain Reaction, Rats, X-Linked Inhibitor of Apoptosis Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.